DK164388A - Praeparater til kontrolleret frigivelse - Google Patents

Praeparater til kontrolleret frigivelse

Info

Publication number
DK164388A
DK164388A DK164388A DK164388A DK164388A DK 164388 A DK164388 A DK 164388A DK 164388 A DK164388 A DK 164388A DK 164388 A DK164388 A DK 164388A DK 164388 A DK164388 A DK 164388A
Authority
DK
Denmark
Prior art keywords
controlled release
release preparations
units
spheroids
zidovudine
Prior art date
Application number
DK164388A
Other languages
English (en)
Other versions
DK175348B1 (da
DK164388D0 (da
Inventor
Harry Phillip Jones
Jobert Judson Mackey
Michael John Desmond Gamlen
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK164388D0 publication Critical patent/DK164388D0/da
Publication of DK164388A publication Critical patent/DK164388A/da
Application granted granted Critical
Publication of DK175348B1 publication Critical patent/DK175348B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK198801643A 1987-03-27 1988-03-25 Orale zidovudinpræparater til kontrolleret frigivelse DK175348B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8707421 1987-03-27
GB878707421A GB8707421D0 (en) 1987-03-27 1987-03-27 Pharmaceutical formulations

Publications (3)

Publication Number Publication Date
DK164388D0 DK164388D0 (da) 1988-03-25
DK164388A true DK164388A (da) 1988-09-28
DK175348B1 DK175348B1 (da) 2004-09-06

Family

ID=10614823

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198801643A DK175348B1 (da) 1987-03-27 1988-03-25 Orale zidovudinpræparater til kontrolleret frigivelse

Country Status (17)

Country Link
US (1) US4917900A (da)
EP (1) EP0284407B1 (da)
JP (1) JP2719344B2 (da)
KR (1) KR960013434B1 (da)
AT (1) ATE63818T1 (da)
AU (1) AU607474B2 (da)
CA (1) CA1308026C (da)
DE (1) DE3862974D1 (da)
DK (1) DK175348B1 (da)
ES (1) ES2033426T3 (da)
GB (1) GB8707421D0 (da)
GR (1) GR3002030T3 (da)
IE (1) IE60605B1 (da)
IL (1) IL85870A (da)
NZ (1) NZ224026A (da)
PT (1) PT87081B (da)
ZA (1) ZA882168B (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051361A (en) * 1988-10-19 1991-09-24 Sigma Chemical Company AZT immunoassays, derivatives, conjugates and antibodies
US4938966A (en) * 1988-11-30 1990-07-03 Riker Laboratories, Inc. Controlled release flecainide acetate formulation
GB8912420D0 (en) 1989-05-31 1989-07-19 Schram Cornelius J Ultrasonic systems
EP0452862B1 (en) * 1990-04-18 1995-07-19 Asahi Kasei Kogyo Kabushiki Kaisha Spherical seed cores, spherical granules and process for production thereof
US5102668A (en) * 1990-10-05 1992-04-07 Kingaform Technology, Inc. Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
ES2085023T3 (es) * 1991-06-21 1996-05-16 Acic Canada Inc Procedimientos para la produccion de zidovudina.
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
ATE186544T1 (de) * 1992-08-04 1999-11-15 James M Dunn Pharmazeutische formulierungen mit kontrollierter freigabe von 3'-azido-3'-deoxythymidin und verfahren zur verwendung
FR2698560B1 (fr) * 1992-11-30 1995-02-03 Virbac Laboratoires Principes actifs pulvérulents stabilisés, compositions les contenant, leur procédé d'obtention et leurs applications.
US6245351B1 (en) 1996-03-07 2001-06-12 Takeda Chemical Industries, Ltd. Controlled-release composition
DE19945982A1 (de) * 1999-09-24 2001-03-29 Knoll Ag Geschwindigkeitsbestimmte Partikel
AU2276801A (en) 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
WO2001045668A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
BR0109602A (pt) * 2000-03-30 2004-06-29 Bristol Myers Squibb Co Glóbulos de liberação controlada contendo estavudina
EP1516907B1 (en) * 2002-06-24 2012-01-25 Adeka Corporation Flame retarder composition and flame retardant resin composition containing the composition
JP2006508134A (ja) * 2002-11-08 2006-03-09 グラクソ グループ リミテッド 医薬組成物
MXPA06003479A (es) * 2003-10-01 2006-06-08 Lupin Ltd Una composicion farmaceutica de liberacion prolongada y un proceso para su preparacion.
GB0403247D0 (en) * 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
EP1730516A1 (en) * 2004-03-30 2006-12-13 Pfizer Products Incorporated Method and device for evaluation of pharmaceutical compositions
WO2008065502A1 (en) * 2006-11-29 2008-06-05 Pfizer Products Inc. Pharmaceutical compositions based on a) nanoparticles comprising enteric polymers and b) casein
WO2008125940A2 (en) * 2007-04-17 2008-10-23 Pfizer Products Inc. Nanoparticles comprising non-crystalline drug
US8703204B2 (en) * 2007-05-03 2014-04-22 Bend Research, Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
WO2008135852A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Pharmaceutical compositions comprising nanoparticles and casein
US8309129B2 (en) * 2007-05-03 2012-11-13 Bend Research, Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
EP2162120B1 (en) * 2007-06-04 2016-05-04 Bend Research, Inc Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
US20100215747A1 (en) * 2007-07-13 2010-08-26 Corey Jay Bloom Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
WO2009073216A1 (en) * 2007-12-06 2009-06-11 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an amine-functionalized methacrylate copolymer
EP2231169B1 (en) * 2007-12-06 2016-05-04 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
US20140271893A1 (en) * 2013-03-15 2014-09-18 Mcneil-Ppc, Inc. Coated phenylephrine particles and use thereof in pharmaceutical formulations
ITUA20161799A1 (it) * 2016-03-18 2017-09-18 Recordati Ind Chimica E Farmaceutica S P A Composizione farmaceutica a rilascio prolungato comprendente cisteamina o un suo sale
CN106333957A (zh) * 2016-08-19 2017-01-18 丁静 齐多夫定用于制备自身免疫性神经炎治疗药物的应用
WO2019038430A1 (en) * 2017-08-25 2019-02-28 Eleonor Sprl COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERIN ALKALOID AND METHOD FOR PRODUCING THE SAME

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE145365C (da) *
BE785702A (fr) * 1971-07-14 1972-10-16 Roehm Gmbh Produits de revetement de formes medicamenteuses et leur utilisation
BE787973A (fr) * 1971-09-04 1973-02-26 Beecham Group Ltd Comprimes pharmaceutiques a effet retard
ES438635A1 (es) * 1974-06-24 1977-02-16 Shinetsu Chemical Co Procedimiento para el revestimiento de moldes solidos de do-sificacion.
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
EP0052076B1 (de) * 1980-11-12 1985-05-29 Ciba-Geigy Ag Schnellzerfallende Arzneimittel-Presslinge
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
DE3126703A1 (de) * 1981-07-07 1983-01-27 Dr. Karl Thomae Gmbh, 7950 Biberach Bromhexin-retardform und verfahren zu ihrer herstellung
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
IT1168014B (it) * 1981-08-05 1987-05-20 Erba Farmitalia Forme farmaceutiche a cessione protratta
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
CH658188A5 (de) * 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
ATE113603T1 (de) * 1985-03-16 1994-11-15 Wellcome Found Antivirale nukleoside.
IE73219B1 (en) * 1985-03-16 1997-05-07 Wellcome Found Therapeutic nucleosides
GB8506869D0 (en) * 1985-03-16 1985-04-17 Wellcome Found Antiviral compound
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
IT1227336B (it) * 1987-09-11 1991-04-08 Squibb & Sons Inc Composizione farmaceutica contenente un carico elevato di medicamento e procedimento per la sua preparazione

Also Published As

Publication number Publication date
NZ224026A (en) 1991-03-26
EP0284407A2 (en) 1988-09-28
CA1308026C (en) 1992-09-29
AU607474B2 (en) 1991-03-07
DK175348B1 (da) 2004-09-06
DK164388D0 (da) 1988-03-25
DE3862974D1 (de) 1991-07-04
EP0284407B1 (en) 1991-05-29
US4917900A (en) 1990-04-17
PT87081A (pt) 1988-04-01
IE60605B1 (en) 1994-07-27
KR960013434B1 (ko) 1996-10-05
ZA882168B (en) 1989-11-29
IE880899L (en) 1988-09-27
GB8707421D0 (en) 1987-04-29
AU1375688A (en) 1988-09-29
PT87081B (pt) 1992-07-31
ATE63818T1 (de) 1991-06-15
JP2719344B2 (ja) 1998-02-25
JPS63255230A (ja) 1988-10-21
GR3002030T3 (en) 1992-12-30
ES2033426T3 (es) 1993-03-16
EP0284407A3 (en) 1988-12-14
IL85870A (en) 1992-02-16
KR880010759A (ko) 1988-10-24

Similar Documents

Publication Publication Date Title
DK164388D0 (da) Praeparater til kontrolleret frigivelse
DE3886965D1 (de) Zubereitungen zur gesteuerten Wirkstofffreisetzung.
DE3853566D1 (de) Formulierungen von Tetrazyklinverbindungen mit kontrollierter Freisetzung.
DE3785570D1 (de) Zusammensetzungen enthaltend lhrh-analoga.
TR28014A (tr) Yanginla mücadele deneme calismasi hangari.
IT8622332A0 (it) Scarponi da sci.
FR2617032B1 (fr) Saupoudreuse
DK335979A (da) 2-cycloalkyl-pyrimidin (5)yl-(thiono) (thiol)-phosphor (phosphon)-syreestere eller esteramider, fremgangsmaade til deres fremstilling samt deres anvendelse som insecticider acaricider og nematodicider
IT8805224A0 (it) Composizione a base di poliesteri per la liberazione controllata di sostanze medicamentose.
ES2054029T3 (es) Formulacion de acetato de flecainida con liberacion controlada.
NO165542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
DE3877747D1 (de) Glasartige matrize zur verabreichung von heilmitteln.
DK501788D0 (da) Anvendelse af visse 6-mercaptopuriner til fremstilling af laegemidler
IT1226580B (it) Scarpone da sci.
DK213976A (da) O-triazolyl (thiono) (thiol)-phosphor(phosphon)-syreestere elller -esteramider fremgangsmade til deres fremstilling og deres anvendelse som insecticider og acaricider
DK68790D0 (da) Anvendelse af tripeptidet l-pyroglutamyl-l-histidylglycin til fremstilling af laegemidler
IT8120673A0 (it) Impianto di trattamento di articoli azionati da aria.
BR8604348A (pt) O jogo da,constituinte simplificado
BR8807597A (pt) Bocal vaporizador
AR228842Q (es) Novedosos derivados de 4,4'-divinil-estilbeno utilizables como blanqueadores opticos,su preparacion y las composiciones que los contienen
DK578487D0 (da) Forstoevningsanlaeg
IT8722591A0 (it) Formulazione farmaceutica contenente gemfibrozilmicroincapsulato.
IT1210429B (it) Scarpone da sci.
IT8782545A0 (it) Scarpone da sci.
IT8782623A0 (it) Scarpone da sci.

Legal Events

Date Code Title Description
PBP Patent lapsed
PUP Patent expired